Skip to main content
. 2013 Apr;11(3):191–205. doi: 10.1089/adt.2012.477

Table 2.

Validation of Multiplexed-Assay

Gene EGFP gaina Cell viabilityb Gene knockdownc Reference
EIF2C2 (Ago2) 2/3 siRNA No effect 2/3 siRNA 12
DGCR8 3/3 siRNA 1/3 siRNA toxic 1/3 siRNA 9
DROSHA (RNASEN) 2/3 siRNA 1/3 siRNA toxic 3/3 siRNA 7,8
TNRC6B 1/3 siRNA No effect 3/3 siRNA 31
DICER1 2/3 siRNA 2/3 siRNA toxic 3/3 siRNA 11
TARBP2 1/3 siRNA 1/3 siRNA toxic 3/3 siRNA 30
EIF2C1 (Ago1) No gain 1/3 siRNA toxic 3/3 siRNA 28
EIF2C3 (Ago3) 2/3 siRNA 1/3 siRNA toxic 0/3 siRNA 28
EIF2C4 (Ago4) No gain No effect 2/3 siRNA 28
TNRC6A No gain No effect 2/3 siRNA 31
TNRC6C No gain No effect 2/3 siRNA 31
DHX9 No gain 1/3 siRNA toxic 3/3 siRNA 27
XPO5 No gain No effect 3/3 siRNA 10
MOV10 1/3 siRNA 1/3 siRNA toxic 3/3 siRNA 29
SCPEP1 No gain 1/3 siRNA toxic 3/3 siRNA 32
KIF11 No gain 3/3 siRNA toxic 3/3 siRNA 33
PLK1 1/3 siRNA 3/3 siRNA toxic 3/3 siRNA 34
a

Number of siRNA for given gene resulting in >2σ EGFP fluorescence above background as determined by Silencer Select Negative Control #1 siRNA.

b

Number of siRNA resulting in cytotoxicity with >80% inhibition relative to data median.

c

Number of siRNA resulting in knockdown using a threshold of 40% gene expression remaining.